[go: up one dir, main page]

SE9603465D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9603465D0
SE9603465D0 SE9603465A SE9603465A SE9603465D0 SE 9603465 D0 SE9603465 D0 SE 9603465D0 SE 9603465 A SE9603465 A SE 9603465A SE 9603465 A SE9603465 A SE 9603465A SE 9603465 D0 SE9603465 D0 SE 9603465D0
Authority
SE
Sweden
Prior art keywords
side chains
amino acid
residue
ile
isoleucine
Prior art date
Application number
SE9603465A
Other languages
English (en)
Inventor
Haakan Bergstrand
Tomas Eriksson
Magnus Lindvall
Bengt Saernstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9603465A priority Critical patent/SE9603465D0/sv
Publication of SE9603465D0 publication Critical patent/SE9603465D0/sv
Priority to AU44060/97A priority patent/AU4406097A/en
Priority to PCT/SE1997/001551 priority patent/WO1998012217A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE9603465A 1996-09-23 1996-09-23 New compounds SE9603465D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9603465A SE9603465D0 (sv) 1996-09-23 1996-09-23 New compounds
AU44060/97A AU4406097A (en) 1996-09-23 1997-09-15 Heterodimer peptides with immunomodulatory effect
PCT/SE1997/001551 WO1998012217A1 (en) 1996-09-23 1997-09-15 Heterodimer peptides with immunomodulatory effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603465A SE9603465D0 (sv) 1996-09-23 1996-09-23 New compounds

Publications (1)

Publication Number Publication Date
SE9603465D0 true SE9603465D0 (sv) 1996-09-23

Family

ID=20403987

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9603465A SE9603465D0 (sv) 1996-09-23 1996-09-23 New compounds

Country Status (3)

Country Link
AU (1) AU4406097A (sv)
SE (1) SE9603465D0 (sv)
WO (1) WO1998012217A1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
AU2015240527B2 (en) 2014-04-03 2019-09-26 Amgen Inc. Method for preparing AMG 416
US10533016B2 (en) 2015-01-09 2020-01-14 Revolution Medicines, Inc. Compounds that participate in cooperative binding and uses thereof
WO2017059207A1 (en) 2015-10-01 2017-04-06 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
KR102359972B1 (ko) 2016-04-12 2022-02-10 징코 바이오웍스, 인크. 화합물의 제조를 위한 조성물 및 방법
US11479797B2 (en) 2016-10-28 2022-10-25 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
US11566007B2 (en) 2019-11-04 2023-01-31 Revolution Medicines, Inc. Ras inhibitors
CN114901366A (zh) 2019-11-04 2022-08-12 锐新医药公司 Ras抑制剂
TW202132314A (zh) 2019-11-04 2021-09-01 美商銳新醫藥公司 Ｒａｓ抑制劑
KR20230067635A (ko) 2020-09-15 2023-05-16 레볼루션 메디슨즈, 인크. 암의 치료에서 ras 억제제로서 인돌 유도체
JP2024517845A (ja) 2021-05-05 2024-04-23 レボリューション メディシンズ インコーポレイテッド がん治療のためのｒａｓ阻害剤
AR127308A1 (es) 2021-10-08 2024-01-10 Revolution Medicines Inc Inhibidores ras

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4309391C2 (de) * 1993-03-23 1996-10-24 Harald Prof Dr Tschesche Verwendung von Angiogenin und/oder dessen Fragmenten als Wirkstoff zur Verhinderung oder Begrenzung der Sekretion von Proteinen aus Leukozyten
AU2964295A (en) * 1994-07-11 1996-02-09 Athena Neurosciences, Inc. Inhibitors of leukocyte adhesion
SE9403526D0 (sv) * 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) * 1995-03-24 1995-03-24 Astra Ab New peptides

Also Published As

Publication number Publication date
AU4406097A (en) 1998-04-14
WO1998012217A1 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
SE9603465D0 (sv) New compounds
TW251274B (sv)
HUP0102900A2 (hu) Javított szilárd fázisú peptidszintézis és a szintézisben alkalmazható anyagok
IT1227907B (it) Procedimento per la sintesi di peptidi retro-inversi e nuovi intermediin tale procedimento
WO1996016982A3 (en) Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
DE69017180D1 (de) Biologisch wirksame polymere arzneistoffderivate.
EP0498784A3 (en) Inhibitors of retroviral protease
DK0437556T3 (da) Substitutionsanaloger af magaininpeptider
EP1006126A3 (en) Osteogenic peptides
ES8107247A1 (es) Procedimiento de fabricacion de compuestos que resultan de la fijacion de muramilpeptidos, sus homologos y derivados
DE69722618D1 (en) Peptide
ATE42308T1 (de) Pharmakologisch aktive peptide.
ATE82984T1 (de) Hemmende peptide.
GB1508681A (en) Synthesis of peptides
AR009807A1 (es) Peptidos que contienen analogos de cisteina.
EP0258203A3 (en) Novel substrate peptides
ATE30919T1 (de) Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DE60109412D1 (en) Therapeutische peptide
FR2575163B1 (fr) Tri- et tetrapeptides reduits inhibiteurs de la secretion gastrique, procede d'obtention et compositions pharmaceutiques les contenant
EP1213297A4 (en) NOVEL TACHYKININ PEPTIDES, THEIR PRECURSOR PEPTIDES AND GENES ENCODING THEM
KR920703634A (ko) 염증 부위로 부터 정제된 포스포리파제 a₂의 펩타이드 저해제
RO91182B (ro) Procedeu pentru prepararea unor peptide
ATE283276T1 (de) Deoxyhypusin reagenz und peptide
AR009805A1 (es) Peptidos que contienen cisteina
KR850006940A (ko) 레닌 억제제의 제조방법